Activated sputum eosinophils associated with exacerbations in children on mepolizumab-Reference-Cited by-同舟云学术

Activated sputum eosinophils associated with exacerbations in children on mepolizumab

Published:2024-08 Issue:2 Volume:154 Page:297-307.e13
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Wilson Gabriella E.,Knight James,Liu Qing,Shelar Ashish,Stewart Emma,Wang Xiaomei,Yan Xiting,Sanders Joshua,Visness Cynthia,Gill Michelle,Gruchalla Rebecca,Liu Andrew H.,Kattan Meyer,Khurana Hershey Gurjit K.,Togias Alkis,Becker Patrice M.,Altman Matthew C.,Busse William W.,Jackson Daniel J.,Montgomery Ruth R.,Chupp Geoffrey L.^ORCID

Funder

GlaxoSmithKline Inc

National Institutes of Health

GlaxoSmithKline

National Institute of Allergy and Infectious Diseases

Publisher

Elsevier BV

Reference35 articles.

1. Worldwide trends in the burden of asthma symptoms in school-aged children: Global Asthma Network Phase I cross-sectional study;Asher;Lancet,2021

2. Patient characteristics, biomarkers and exacerbation risk in severe, uncontrolled asthma;Kraft;Eur Respir J,2021

3. Th2 cytokines and asthma. The role of interleukin-5 in allergic eosinophilic disease;Greenfeder;Respir Res,2001

4. Weight-adjusted intravenous reslizumab in severe asthma with inadequate response to fixed-dose subcutaneous mepolizumab;Mukherjee;Am J Respir Crit Care Med,2018

5. Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial;Pavord;Lancet,2012

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The immunoregulatory potential of eosinophil subsets;Immunology & Cell Biology;2024-09-13

2. Does Eosinophil Heterogeneity Translate into Functional Diversity? A Review of the Evolving Paradigm of Eosinophil Heterogeneity in Asthma;Biomedicines;2024-09-03

3. Can sputum eosinophils predict a poor response to mepolizumab?;Journal of Allergy and Clinical Immunology;2024-08

4. Mepolizumab in Severe Pediatric Asthma: Certainties and Doubts through a Single-Center Experience and Review of the Literature;Children;2024-07-25